<?xml version="1.0" encoding="UTF-8"?>
<funding-group>
 <award-group id="award001">
  <funding-source>
   <institution>INFRAVEC2</institution>
  </funding-source>
  <award-id>731060</award-id>
  <principal-award-recipient>
   <contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-1654-9383</contrib-id>
   <name>
    <surname>Moretti</surname>
    <given-names>Riccardo</given-names>
   </name>
  </principal-award-recipient>
 </award-group>
 <funding-statement>This project has received resources funded by the European Unionâ€™s Horizon 2020 research and innovation programme under grant agreement No 731060 (Infravec2, Research Infrastructures for the control of vector-borne diseases; 
  <ext-link ext-link-type="uri" xlink:href="http://infravec2.eu/" xmlns:xlink="http://www.w3.org/1999/xlink">http://infravec2.eu/</ext-link>). Funding followed the positive evaluation of a formal request describing the research project which was prepared and submitted to Infravec2 by RM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
 </funding-statement>
</funding-group>
